Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Long-Term Investments (2016 - 2025)

Icu Medical (ICUI) has disclosed Long-Term Investments for 9 consecutive years, with $131.6 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Long-Term Investments changed N/A year-over-year to $131.6 million, compared with a TTM value of $131.6 million through Jun 2025, changed N/A, and an annual FY2024 reading of $3.0 million, changed N/A over the prior year.
  • Long-Term Investments was $131.6 million for Q2 2025 at Icu Medical, up from $3.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $131.6 million in Q2 2025 and bottomed at $516000.0 in Q4 2022.
  • Average Long-Term Investments over 4 years is $28.5 million, with a median of $3.0 million recorded in 2024.
  • The sharpest move saw Long-Term Investments tumbled 64.39% in 2021, then plummeted 88.83% in 2022.
  • Year by year, Long-Term Investments stood at $4.6 million in 2021, then tumbled by 88.83% to $516000.0 in 2022, then skyrocketed by 488.76% to $3.0 million in 2024, then skyrocketed by 4232.62% to $131.6 million in 2025.
  • Business Quant data shows Long-Term Investments for ICUI at $131.6 million in Q2 2025, $3.0 million in Q4 2024, and $516000.0 in Q4 2022.